Center for Drug Evaluation and Research
GPTKB entity
Statements (22)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:government_agency
|
| gptkbp:abbreviation |
gptkb:CDER
|
| gptkbp:country |
gptkb:United_States
|
| gptkbp:director |
gptkb:Patrizia_Cavazzoni
|
| gptkbp:division |
gptkb:U.S._Department_of_Health_and_Human_Services
|
| gptkbp:establishedIn |
1988
|
| gptkbp:headquartersLocation |
gptkb:Silver_Spring,_Maryland
|
| gptkbp:language |
English
|
| gptkbp:oversees |
new drug applications
clinical trial oversight generic drug approvals post-market drug safety |
| gptkbp:parentOrganization |
gptkb:U.S._Food_and_Drug_Administration
|
| gptkbp:partOf |
gptkb:U.S._Food_and_Drug_Administration
|
| gptkbp:responsibleFor |
ensuring drug efficacy
ensuring drug safety regulation of over-the-counter drugs regulation of prescription drugs |
| gptkbp:website |
https://www.fda.gov/about-fda/center-drug-evaluation-and-research-cder
|
| gptkbp:bfsParent |
gptkb:FDA
gptkb:accelerated_approval |
| gptkbp:bfsLayer |
5
|